[
  {
    "molecule": "Pembrolizumab",
    "brand": "Keytruda",
    "region": "Global",
    "therapy_area": "Oncology",
    "indication": "NSCLC, Melanoma, TNBC",
    "market_size_usd_mn": 25000,
    "cagr_percent": 12.5,
    "top_competitors": [
      "Nivolumab",
      "Atezolizumab",
      "Durvalumab"
    ],
    "generic_penetration": "Low",
    "patient_burden": "High",
    "competition_level": "Low"
  },
  {
    "molecule": "Sitagliptin",
    "brand": "Januvia",
    "region": "India",
    "therapy_area": "Diabetes",
    "indication": "Type 2 Diabetes",
    "market_size_usd_mn": 150,
    "cagr_percent": 8.0,
    "top_competitors": [
      "Vildagliptin",
      "Teneligliptin",
      "Linagliptin"
    ],
    "generic_penetration": "High",
    "patient_burden": "Very High",
    "competition_level": "High"
  },
  {
    "molecule": "Rivaroxaban",
    "brand": "Xarelto",
    "region": "US",
    "therapy_area": "Cardiovascular",
    "indication": "DVT, PE, Stroke Prevention",
    "market_size_usd_mn": 4000,
    "cagr_percent": 5.2,
    "top_competitors": [
      "Apixaban",
      "Warfarin",
      "Edoxaban"
    ],
    "generic_penetration": "Medium",
    "patient_burden": "High",
    "competition_level": "Medium"
  },
  {
    "molecule": "Pirfenidone",
    "brand": "Esbriet",
    "region": "India",
    "therapy_area": "Respiratory",
    "indication": "Idiopathic Pulmonary Fibrosis",
    "market_size_usd_mn": 45,
    "cagr_percent": 18.5,
    "top_competitors": [
      "Nintedanib"
    ],
    "generic_penetration": "Low",
    "patient_burden": "High",
    "competition_level": "Low"
  },
  {
    "molecule": "Roflumilast",
    "brand": "Daxas",
    "region": "India",
    "therapy_area": "Respiratory",
    "indication": "Severe COPD",
    "market_size_usd_mn": 28,
    "cagr_percent": 14.2,
    "top_competitors": [
      "Theophylline"
    ],
    "generic_penetration": "Low",
    "patient_burden": "Very High",
    "competition_level": "Low"
  },
  {
    "molecule": "Fluticasone",
    "brand": "Flovent/Flonase",
    "region": "India",
    "therapy_area": "Respiratory",
    "indication": "Asthma, Allergic Rhinitis",
    "market_size_usd_mn": 320,
    "cagr_percent": 6.1,
    "top_competitors": [
      "Budesonide",
      "Beclometasone",
      "Ciclesonide",
      "Mometasone"
    ],
    "generic_penetration": "High",
    "patient_burden": "Very High",
    "competition_level": "High"
  },
  {
    "molecule": "Omalizumab",
    "brand": "Xolair",
    "region": "India",
    "therapy_area": "Respiratory",
    "indication": "Severe Allergic Asthma",
    "market_size_usd_mn": 65,
    "cagr_percent": 22.0,
    "top_competitors": [
      "Mepolizumab",
      "Benralizumab",
      "Dupilumab"
    ],
    "generic_penetration": "Low",
    "patient_burden": "High",
    "competition_level": "Low"
  },
  {
    "molecule": "Tiotropium",
    "brand": "Spiriva",
    "region": "India",
    "therapy_area": "Respiratory",
    "indication": "COPD Maintenance",
    "market_size_usd_mn": 85,
    "cagr_percent": 9.8,
    "top_competitors": [
      "Glycopyrronium",
      "Umeclidinium",
      "Aclidinium"
    ],
    "generic_penetration": "Medium",
    "patient_burden": "Very High",
    "competition_level": "Medium"
  },
  {
    "molecule": "Paracetamol",
    "brand": "Dolo 650",
    "region": "India",
    "therapy_area": "Analgesic",
    "indication": "Fever, Pain, Headache",
    "market_size_usd_mn": 420,
    "cagr_percent": 6.2,
    "top_competitors": [
      "Calpol",
      "Crocin",
      "Tylenol"
    ],
    "generic_penetration": "High",
    "patient_burden": "Very High",
    "competition_level": "High"
  },
  {
    "molecule": "Azithromycin",
    "brand": "Azithral",
    "region": "India",
    "therapy_area": "Anti-infective",
    "indication": "Respiratory Infections, UTI",
    "market_size_usd_mn": 380,
    "cagr_percent": 4.8,
    "top_competitors": [
      "Clarithromycin",
      "Amoxicillin",
      "Levofloxacin"
    ],
    "generic_penetration": "High",
    "patient_burden": "High",
    "competition_level": "High"
  },
  {
    "molecule": "Pantoprazole",
    "brand": "Pan 40",
    "region": "India",
    "therapy_area": "Gastrointestinal",
    "indication": "GERD, Peptic Ulcer",
    "market_size_usd_mn": 520,
    "cagr_percent": 7.3,
    "top_competitors": [
      "Omeprazole",
      "Esomeprazole",
      "Rabeprazole"
    ],
    "generic_penetration": "High",
    "patient_burden": "High",
    "competition_level": "High"
  },
  {
    "molecule": "Atorvastatin",
    "brand": "Lipitor/Atorva",
    "region": "Global",
    "therapy_area": "Cardiovascular",
    "indication": "Hypercholesterolemia, CVD Prevention",
    "market_size_usd_mn": 2800,
    "cagr_percent": 3.5,
    "top_competitors": [
      "Rosuvastatin",
      "Simvastatin",
      "Pravastatin"
    ],
    "generic_penetration": "High",
    "patient_burden": "Very High",
    "competition_level": "High"
  },
  {
    "molecule": "Metformin",
    "brand": "Glycomet/Glucophage",
    "region": "Global",
    "therapy_area": "Diabetes",
    "indication": "Type 2 Diabetes",
    "market_size_usd_mn": 890,
    "cagr_percent": 4.2,
    "top_competitors": [
      "Glimepiride",
      "Gliclazide"
    ],
    "generic_penetration": "High",
    "patient_burden": "Very High",
    "competition_level": "High"
  },
  {
    "molecule": "Semaglutide",
    "brand": "Ozempic/Wegovy",
    "region": "Global",
    "therapy_area": "Diabetes",
    "indication": "Type 2 Diabetes, Obesity",
    "market_size_usd_mn": 18500,
    "cagr_percent": 45.2,
    "top_competitors": [
      "Tirzepatide",
      "Liraglutide",
      "Dulaglutide"
    ],
    "generic_penetration": "Low",
    "patient_burden": "Very High",
    "competition_level": "Low"
  },
  {
    "molecule": "Adalimumab",
    "brand": "Humira",
    "region": "Global",
    "therapy_area": "Autoimmune",
    "indication": "RA, Psoriasis, Crohn's",
    "market_size_usd_mn": 15200,
    "cagr_percent": -8.5,
    "top_competitors": [
      "Biosimilars",
      "Upadacitinib",
      "Secukinumab"
    ],
    "generic_penetration": "Medium",
    "patient_burden": "High",
    "competition_level": "High"
  },
  {
    "molecule": "Escitalopram",
    "brand": "Lexapro/Nexito",
    "region": "India",
    "therapy_area": "CNS",
    "indication": "Depression, Anxiety",
    "market_size_usd_mn": 210,
    "cagr_percent": 11.5,
    "top_competitors": [
      "Sertraline",
      "Fluoxetine",
      "Venlafaxine"
    ],
    "generic_penetration": "High",
    "patient_burden": "High",
    "competition_level": "High"
  },
  {
    "molecule": "Montelukast",
    "brand": "Singulair/Montair",
    "region": "India",
    "therapy_area": "Respiratory",
    "indication": "Asthma, Allergic Rhinitis",
    "market_size_usd_mn": 280,
    "cagr_percent": 8.9,
    "top_competitors": [
      "Zafirlukast"
    ],
    "generic_penetration": "High",
    "patient_burden": "Very High",
    "competition_level": "Medium"
  },
  {
    "molecule": "Trastuzumab",
    "brand": "Herceptin",
    "region": "Global",
    "therapy_area": "Oncology",
    "indication": "HER2+ Breast Cancer",
    "market_size_usd_mn": 5800,
    "cagr_percent": -2.5,
    "top_competitors": [
      "Biosimilars",
      "Pertuzumab",
      "T-DM1"
    ],
    "generic_penetration": "Medium",
    "patient_burden": "High",
    "competition_level": "Medium"
  },
  {
    "molecule": "Lenalidomide",
    "brand": "Revlimid",
    "region": "Global",
    "therapy_area": "Oncology",
    "indication": "Multiple Myeloma, MDS",
    "market_size_usd_mn": 9200,
    "cagr_percent": -15.0,
    "top_competitors": [
      "Pomalidomide",
      "Generics"
    ],
    "generic_penetration": "Medium",
    "patient_burden": "High",
    "competition_level": "Medium"
  },
  {
    "molecule": "Amlodipine",
    "brand": "Norvasc/Amlopin",
    "region": "India",
    "therapy_area": "Cardiovascular",
    "indication": "Hypertension, Angina",
    "market_size_usd_mn": 340,
    "cagr_percent": 5.8,
    "top_competitors": [
      "Nifedipine",
      "Cilnidipine",
      "Telmisartan"
    ],
    "generic_penetration": "High",
    "patient_burden": "Very High",
    "competition_level": "High"
  }
]